nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4C—brainstem—malignant glioma	0.0251	0.0517	CbGeAlD
Flavoxate—PDE8B—telencephalon—malignant glioma	0.024	0.0495	CbGeAlD
Flavoxate—PDE4C—telencephalon—malignant glioma	0.0222	0.0459	CbGeAlD
Flavoxate—PDE8A—telencephalon—malignant glioma	0.0216	0.0445	CbGeAlD
Flavoxate—PDE7A—central nervous system—malignant glioma	0.0196	0.0404	CbGeAlD
Flavoxate—PDE4D—telencephalon—malignant glioma	0.0196	0.0404	CbGeAlD
Flavoxate—PDE4A—telencephalon—malignant glioma	0.0173	0.0357	CbGeAlD
Flavoxate—PDE8B—midbrain—malignant glioma	0.0172	0.0356	CbGeAlD
Flavoxate—PDE7B—central nervous system—malignant glioma	0.0171	0.0354	CbGeAlD
Flavoxate—PDE8A—medulla oblongata—malignant glioma	0.017	0.035	CbGeAlD
Flavoxate—PDE4C—midbrain—malignant glioma	0.016	0.0329	CbGeAlD
Flavoxate—PDE7A—brain—malignant glioma	0.0156	0.0321	CbGeAlD
Flavoxate—PDE8A—midbrain—malignant glioma	0.0155	0.032	CbGeAlD
Flavoxate—Antrafenine—PTGS1—malignant glioma	0.0153	0.398	CrCbGaD
Flavoxate—PDE8A—spinal cord—malignant glioma	0.0151	0.0312	CbGeAlD
Flavoxate—Raloxifene—CYP2B6—malignant glioma	0.0144	0.375	CrCbGaD
Flavoxate—PDE8B—central nervous system—malignant glioma	0.0136	0.0281	CbGeAlD
Flavoxate—PDE7B—brain—malignant glioma	0.0136	0.0281	CbGeAlD
Flavoxate—PDE8B—cerebellum—malignant glioma	0.0133	0.0275	CbGeAlD
Flavoxate—PDE4C—central nervous system—malignant glioma	0.0126	0.0261	CbGeAlD
Flavoxate—PDE8A—cerebellum—malignant glioma	0.012	0.0247	CbGeAlD
Flavoxate—PDE4D—cerebellum—malignant glioma	0.0109	0.0224	CbGeAlD
Flavoxate—PDE8B—brain—malignant glioma	0.0108	0.0223	CbGeAlD
Flavoxate—PDE4B—telencephalon—malignant glioma	0.0103	0.0213	CbGeAlD
Flavoxate—CHRM2—telencephalon—malignant glioma	0.0103	0.0212	CbGeAlD
Flavoxate—PDE4C—brain—malignant glioma	0.01	0.0207	CbGeAlD
Flavoxate—PDE8A—brain—malignant glioma	0.00975	0.0201	CbGeAlD
Flavoxate—PDE4A—cerebellum—malignant glioma	0.00962	0.0198	CbGeAlD
Flavoxate—CHRM1—telencephalon—malignant glioma	0.00934	0.0193	CbGeAlD
Flavoxate—PDE4D—brain—malignant glioma	0.00883	0.0182	CbGeAlD
Flavoxate—Antrafenine—PTGS2—malignant glioma	0.00874	0.227	CrCbGaD
Flavoxate—PDE4B—medulla oblongata—malignant glioma	0.00811	0.0167	CbGeAlD
Flavoxate—PDE4A—brain—malignant glioma	0.00782	0.0161	CbGeAlD
Flavoxate—PDE4B—midbrain—malignant glioma	0.00742	0.0153	CbGeAlD
Flavoxate—PDE4B—spinal cord—malignant glioma	0.00724	0.0149	CbGeAlD
Flavoxate—PDE4B—central nervous system—malignant glioma	0.00587	0.0121	CbGeAlD
Flavoxate—CHRM2—central nervous system—malignant glioma	0.00583	0.012	CbGeAlD
Flavoxate—PDE4B—cerebellum—malignant glioma	0.00574	0.0118	CbGeAlD
Flavoxate—CHRM1—central nervous system—malignant glioma	0.00531	0.0109	CbGeAlD
Flavoxate—PDE4B—brain—malignant glioma	0.00466	0.00961	CbGeAlD
Flavoxate—CHRM2—brain—malignant glioma	0.00463	0.00955	CbGeAlD
Flavoxate—CHRM1—brain—malignant glioma	0.00421	0.00869	CbGeAlD
Flavoxate—PDE7B—Signaling Pathways—TP53—malignant glioma	0.00014	0.000293	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCL8—malignant glioma	0.000138	0.000289	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FGF2—malignant glioma	0.000137	0.000288	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CD—malignant glioma	0.000136	0.000286	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000135	0.000283	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BRAF—malignant glioma	0.000135	0.000283	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PIK3CA—malignant glioma	0.000134	0.000282	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—KRAS—malignant glioma	0.000134	0.00028	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AKT1—malignant glioma	0.000133	0.000279	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AKT1—malignant glioma	0.000132	0.000278	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AKT1—malignant glioma	0.000132	0.000278	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CASP3—malignant glioma	0.000132	0.000277	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—malignant glioma	0.000132	0.000276	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT2—malignant glioma	0.000131	0.000276	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—malignant glioma	0.000131	0.000274	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FGF2—malignant glioma	0.000131	0.000274	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—malignant glioma	0.00013	0.000272	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PIK3CA—malignant glioma	0.000129	0.00027	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MDM2—malignant glioma	0.000128	0.000269	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RAF1—malignant glioma	0.000128	0.000268	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ERBB2—malignant glioma	0.000127	0.000266	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CD—malignant glioma	0.000126	0.000265	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PIK3CA—malignant glioma	0.000125	0.000262	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CB—malignant glioma	0.000125	0.000262	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—malignant glioma	0.000125	0.000262	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PTEN—malignant glioma	0.000124	0.00026	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—KRAS—malignant glioma	0.000124	0.000259	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PIK3CA—malignant glioma	0.000123	0.000257	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MDM2—malignant glioma	0.000122	0.000256	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RAF1—malignant glioma	0.000122	0.000255	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—H3F3A—malignant glioma	0.000121	0.000254	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AKT1—malignant glioma	0.000121	0.000254	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FGF2—malignant glioma	0.000121	0.000254	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ERBB2—malignant glioma	0.00012	0.000253	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—F2—malignant glioma	0.00012	0.000252	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCL8—malignant glioma	0.00012	0.000252	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCR3—malignant glioma	0.00012	0.000251	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—H3F3A—malignant glioma	0.000119	0.000251	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CB—malignant glioma	0.000119	0.000249	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—F2—malignant glioma	0.000119	0.000249	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCR3—malignant glioma	0.000118	0.000248	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AKT1—malignant glioma	0.000118	0.000247	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—YWHAE—malignant glioma	0.000117	0.000245	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK2—malignant glioma	0.000117	0.000245	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FLT1—malignant glioma	0.000116	0.000243	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AKT1—malignant glioma	0.000116	0.000243	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DUSP6—malignant glioma	0.000116	0.000242	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—YWHAE—malignant glioma	0.000115	0.000241	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK2—malignant glioma	0.000115	0.000241	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000115	0.000241	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CASP3—malignant glioma	0.000115	0.000241	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—malignant glioma	0.000115	0.000241	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FLT1—malignant glioma	0.000115	0.00024	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL8—malignant glioma	0.000114	0.00024	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JAG1—malignant glioma	0.000114	0.000239	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DUSP6—malignant glioma	0.000114	0.000239	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH3—malignant glioma	0.000114	0.000238	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PIK3CA—malignant glioma	0.000114	0.000238	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000113	0.000238	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MDM2—malignant glioma	0.000113	0.000237	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RAF1—malignant glioma	0.000113	0.000236	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JAG1—malignant glioma	0.000113	0.000236	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH3—malignant glioma	0.000112	0.000235	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—malignant glioma	0.000112	0.000235	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FBXW7—malignant glioma	0.000112	0.000234	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ERBB2—malignant glioma	0.000111	0.000234	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—STAT3—malignant glioma	0.000111	0.000233	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AKT1—malignant glioma	0.00011	0.000232	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FBXW7—malignant glioma	0.00011	0.000231	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CB—malignant glioma	0.00011	0.000231	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AKT1—malignant glioma	0.00011	0.00023	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BDKRB2—malignant glioma	0.00011	0.00023	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CASP3—malignant glioma	0.000109	0.000229	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—malignant glioma	0.000109	0.000229	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—F2—malignant glioma	0.000109	0.000229	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—malignant glioma	0.000109	0.000228	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BDKRB2—malignant glioma	0.000108	0.000227	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTEN—malignant glioma	0.000108	0.000226	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—F2—malignant glioma	0.000108	0.000226	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL8—malignant glioma	0.000106	0.000222	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKT1—malignant glioma	0.000105	0.000221	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT2—malignant glioma	0.000105	0.000221	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CG—malignant glioma	0.000104	0.000219	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT2—malignant glioma	0.000104	0.000218	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—malignant glioma	0.000103	0.000217	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CG—malignant glioma	0.000103	0.000216	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—malignant glioma	0.000103	0.000216	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTEN—malignant glioma	0.000103	0.000216	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PTPN11—malignant glioma	0.000103	0.000215	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKT1—malignant glioma	0.000102	0.000214	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH2—malignant glioma	0.000102	0.000214	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PTPN11—malignant glioma	0.000101	0.000212	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CASP3—malignant glioma	0.000101	0.000212	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000101	0.000212	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—malignant glioma	0.000101	0.000212	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—malignant glioma	0.000101	0.000211	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH2—malignant glioma	0.000101	0.000211	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKT1—malignant glioma	0.0001	0.00021	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	9.98e-05	0.000209	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KNG1—malignant glioma	9.97e-05	0.000209	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KNG1—malignant glioma	9.84e-05	0.000206	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—malignant glioma	9.75e-05	0.000205	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—STAT3—malignant glioma	9.65e-05	0.000203	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—malignant glioma	9.56e-05	0.000201	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT2—malignant glioma	9.55e-05	0.0002	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KRAS—malignant glioma	9.52e-05	0.0002	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTEN—malignant glioma	9.51e-05	0.000199	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK1—malignant glioma	9.5e-05	0.000199	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT2—malignant glioma	9.43e-05	0.000198	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK1—malignant glioma	9.38e-05	0.000197	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—malignant glioma	9.28e-05	0.000195	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKT1—malignant glioma	9.27e-05	0.000195	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STAT3—malignant glioma	9.19e-05	0.000193	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CD—malignant glioma	9.18e-05	0.000193	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	9.06e-05	0.00019	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—malignant glioma	8.97e-05	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP3—malignant glioma	8.83e-05	0.000185	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	8.81e-05	0.000185	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—malignant glioma	8.77e-05	0.000184	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	8.76e-05	0.000184	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CA—malignant glioma	8.75e-05	0.000184	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP3—malignant glioma	8.72e-05	0.000183	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	8.7e-05	0.000182	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	8.64e-05	0.000181	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—malignant glioma	8.59e-05	0.00018	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—malignant glioma	8.54e-05	0.000179	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTK2—malignant glioma	8.5e-05	0.000178	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STAT3—malignant glioma	8.5e-05	0.000178	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	8.46e-05	0.000178	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—malignant glioma	8.46e-05	0.000178	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTK2—malignant glioma	8.39e-05	0.000176	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	8.36e-05	0.000175	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HES1—malignant glioma	8.35e-05	0.000175	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—malignant glioma	8.35e-05	0.000175	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NCOR1—malignant glioma	8.31e-05	0.000174	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KRAS—malignant glioma	8.29e-05	0.000174	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HES1—malignant glioma	8.25e-05	0.000173	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NCOR1—malignant glioma	8.2e-05	0.000172	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RAF1—malignant glioma	8.19e-05	0.000172	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—malignant glioma	8.09e-05	0.00017	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RAF1—malignant glioma	8.09e-05	0.00017	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	8e-05	0.000168	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—malignant glioma	7.99e-05	0.000168	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	7.95e-05	0.000167	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—malignant glioma	7.9e-05	0.000166	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	7.9e-05	0.000166	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KRAS—malignant glioma	7.89e-05	0.000166	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	7.85e-05	0.000165	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—malignant glioma	7.73e-05	0.000162	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SPP1—malignant glioma	7.72e-05	0.000162	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	7.69e-05	0.000161	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SPP1—malignant glioma	7.62e-05	0.00016	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CA—malignant glioma	7.62e-05	0.00016	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	7.59e-05	0.000159	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—malignant glioma	7.37e-05	0.000155	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—malignant glioma	7.35e-05	0.000154	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TERT—malignant glioma	7.32e-05	0.000154	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KRAS—malignant glioma	7.3e-05	0.000153	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—malignant glioma	7.25e-05	0.000152	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CA—malignant glioma	7.25e-05	0.000152	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TERT—malignant glioma	7.23e-05	0.000152	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKT1—malignant glioma	7.15e-05	0.00015	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDGFB—malignant glioma	7.14e-05	0.00015	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGFR1—malignant glioma	7.11e-05	0.000149	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDGFB—malignant glioma	7.05e-05	0.000148	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGFR1—malignant glioma	7.02e-05	0.000147	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—malignant glioma	7.01e-05	0.000147	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HIF1A—malignant glioma	7e-05	0.000147	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HIF1A—malignant glioma	6.91e-05	0.000145	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CAV1—malignant glioma	6.77e-05	0.000142	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CA—malignant glioma	6.71e-05	0.000141	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KDR—malignant glioma	6.69e-05	0.00014	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CAV1—malignant glioma	6.68e-05	0.00014	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KDR—malignant glioma	6.61e-05	0.000139	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—malignant glioma	6.49e-05	0.000136	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—F2—malignant glioma	6.44e-05	0.000135	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FN1—malignant glioma	6.44e-05	0.000135	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BAD—malignant glioma	6.37e-05	0.000134	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—F2—malignant glioma	6.36e-05	0.000133	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FN1—malignant glioma	6.36e-05	0.000133	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	6.31e-05	0.000132	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BAD—malignant glioma	6.29e-05	0.000132	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	6.23e-05	0.000131	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKT1—malignant glioma	6.22e-05	0.000131	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CD80—malignant glioma	6.18e-05	0.00013	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APC—malignant glioma	6.17e-05	0.000129	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	6.17e-05	0.000129	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CD80—malignant glioma	6.1e-05	0.000128	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGF—malignant glioma	6.1e-05	0.000128	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	6.09e-05	0.000128	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APC—malignant glioma	6.09e-05	0.000128	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTPN11—malignant glioma	6.06e-05	0.000127	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGF—malignant glioma	6.02e-05	0.000126	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTPN11—malignant glioma	5.98e-05	0.000125	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKT1—malignant glioma	5.92e-05	0.000124	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BRAF—malignant glioma	5.8e-05	0.000122	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BRAF—malignant glioma	5.72e-05	0.00012	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT2—malignant glioma	5.64e-05	0.000118	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—malignant glioma	5.62e-05	0.000118	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT2—malignant glioma	5.57e-05	0.000117	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—malignant glioma	5.55e-05	0.000116	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT1—malignant glioma	5.48e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	5.42e-05	0.000114	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	5.37e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	5.35e-05	0.000112	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—KRAS—malignant glioma	5.31e-05	0.000111	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	5.3e-05	0.000111	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—KRAS—malignant glioma	5.24e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGF2—malignant glioma	5.19e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGF2—malignant glioma	5.12e-05	0.000107	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	4.88e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MDM2—malignant glioma	4.86e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RAF1—malignant glioma	4.84e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	4.81e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MDM2—malignant glioma	4.79e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ERBB2—malignant glioma	4.79e-05	0.0001	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RAF1—malignant glioma	4.78e-05	0.0001	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ERBB2—malignant glioma	4.73e-05	9.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	4.73e-05	9.91e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	4.66e-05	9.79e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL8—malignant glioma	4.54e-05	9.53e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL8—malignant glioma	4.48e-05	9.4e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	4.39e-05	9.2e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CASP3—malignant glioma	4.35e-05	9.12e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—malignant glioma	4.34e-05	9.1e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	4.33e-05	9.08e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CASP3—malignant glioma	4.29e-05	9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—malignant glioma	4.28e-05	8.99e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—malignant glioma	4.11e-05	8.62e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTEN—malignant glioma	4.08e-05	8.57e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.05e-05	8.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.03e-05	8.46e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.98e-05	8.36e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT1—malignant glioma	3.93e-05	8.25e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—malignant glioma	3.69e-05	7.74e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT3—malignant glioma	3.65e-05	7.66e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.64e-05	7.64e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT3—malignant glioma	3.6e-05	7.56e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—malignant glioma	3.39e-05	7.12e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—malignant glioma	3.35e-05	7.03e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—malignant glioma	3.32e-05	6.96e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.28e-05	6.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KRAS—malignant glioma	3.14e-05	6.58e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.1e-05	6.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.88e-05	6.04e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.84e-05	5.96e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—malignant glioma	2.79e-05	5.85e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—malignant glioma	2.75e-05	5.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT1—malignant glioma	2.35e-05	4.94e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.32e-05	4.87e-05	CbGpPWpGaD
